Rankings
▼
Calendar
ARVN (Arvinas, Inc.) Stock Financials & Earnings | Market Cap Arena
ARVN
Arvinas, Inc.
Mkt Cap
$907M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$263M
Net Income (TTM)
-$81M
EPS (TTM)
-$1.22
Free Cash Flow (TTM)
-$276M
Gross Margin
99.5%
Op. Margin
-44.0%
Net Margin
-30.8%
FCF Margin
-105.0%
P/S Ratio (TTM)
3.5x
P/E Ratio (TTM)
—
YoY Rev Growth
-0.3%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$33M
$31M
-$88M
Q2 23
$55M
$53M
-$75M
Q3 23
$35M
$33M
-$74M
Q4 23
-$43M
-$45M
-$165M
Q1 24
$25M
$24M
-$83M
Q2 24
$77M
$75M
-$49M
Q3 24
$102M
$102M
-$60M
Q4 24
$59M
$59M
-$58M
Q1 25
$189M
$189M
$71M
Q2 25
$22M
$22M
-$72M
Q3 25
$42M
$42M
-$44M
Q4 25
$10M
$8M
-$72M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
6.6x
—
Q2 23
5.7x
—
Q3 23
5.7x
—
Q4 23
11.6x
—
Q1 24
12.7x
—
Q2 24
9.7x
—
Q3 24
5.6x
—
Q4 24
3.4x
—
Q1 25
2.1x
—
Q2 25
2.4x
—
Q3 25
2.9x
—
Q4 25
3.5x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$91M
-$92M
Q2 23
-$89M
-$89M
Q3 23
-$85M
-$86M
Q4 23
-$83M
-$83M
Q1 24
-$98M
-$98M
Q2 24
$50M
$50M
Q3 24
-$128M
-$129M
Q4 24
-$84M
-$84M
Q1 25
-$89M
-$89M
Q2 25
-$95M
-$97M
Q3 25
-$59M
-$59M
Q4 25
-$30M
-$31M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$1M
Q2 23
$600K
Q3 23
$1M
Q4 23
$100K
Q1 24
$100K
Q2 24
$700K
Q3 24
$700K
Q4 24
$300K
Q1 25
$400K
Q2 25
$1M
Q3 25
$100K
Q4 25
$200K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+22.6%
+42.8%
Q2 23
+61.2%
+29.6%
Q3 23
+4.2%
+11.3%
Q4 23
-213.4%
+7.8%
Q1 24
-22.2%
-9.7%
Q2 24
+40.4%
-3.2%
Q3 24
+196.0%
+50.0%
Q4 24
+237.4%
-3.9%
Q1 25
+646.2%
+8.1%
Q2 25
-70.7%
-24.9%
Q3 25
-59.1%
-47.3%
Q4 25
-84.0%
-30.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$20M
61.2%
Q2 23
$0
0.0%
Q3 23
$17M
48.3%
Q4 23
$17M
—
Q1 24
$19M
73.5%
Q2 24
$22M
28.2%
Q3 24
$25M
24.1%
Q4 24
$23M
39.4%
Q1 25
$15M
7.9%
Q2 25
$10M
46.0%
Q3 25
$0
0.0%
Q4 25
$9M
89.5%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$95M
—
$23M
Q2 23
$103M
—
$24M
Q3 23
$86M
—
$21M
Q4 23
$95M
$27M
—
Q1 24
$84M
$24M
—
Q2 24
$94M
$31M
—
Q3 24
$87M
$76M
—
Q4 24
$83M
$34M
—
Q1 25
$91M
$27M
—
Q2 25
$69M
$25M
—
Q3 25
$65M
$22M
—
Q4 25
$61M
$22M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$130M
$993M
$1.1B
Q2 23
$91M
$948M
$1.0B
Q3 23
$114M
$885M
$999M
Q4 23
$312M
$949M
$1.3B
Q1 24
$88M
$1.1B
$1.2B
Q2 24
$155M
$1.1B
$1.2B
Q3 24
$85M
$1.0B
$1.1B
Q4 24
$101M
$939M
$1.0B
Q1 25
$81M
$873M
$954M
Q2 25
$115M
$746M
$861M
Q3 25
$102M
$686M
$788M
Q4 25
$143M
$543M
$685M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
53M
+0.2%
Q2 23
53M
+0.2%
Q3 23
54M
+1.3%
Q4 23
61M
+12.9%
Q1 24
72M
+17.3%
Q2 24
72M
+0.3%
Q3 24
72M
+0.3%
Q4 24
72M
+0.0%
Q1 25
73M
+0.8%
Q2 25
73M
+0.4%
Q3 25
73M
-0.1%
Q4 25
65M
-11.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 16
—
—
FY 17
—
—
FY 18
$173K
83
FY 19
$323K
133
FY 20
$145K
179
FY 21
$191K
280
FY 22
$317K
415
FY 23
$176K
445
FY 24
$613K
430
FY 25
$1M
246
marketcaparena.com